Onderneming PDS Biotechnology Corporation
Aandelen
PDSB
US70465T1079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,82 USD | +2,41% | +16,82% | -23,14% |
02/05 | PDS Biotechnology Corporation benoemt Stephan Toutain tot Chief Operating Officer | CI |
28/03 | PDS BIOTECHNOLOGY CORPORATION : B. Riley bevestigt koopadvies | ZM |
Vakgebied
Aantal werknemers: 25
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank Bedu-Addo
FOU | Founder | 59 | 15-03-19 |
Director of Finance/CFO | 55 | 04/12 | |
David Schaaf
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-22 |
Spencer Brown
CMP | Compliance Officer | 54 | 01-06-22 |
Gregory Conn
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-01-05 |
Joe J. Dervan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Glover
CHM | Chairman | 60 | 02-04-19 |
Otis Brawley
BRD | Director/Board Member | 64 | 03-11-20 |
Richard Sykes
BRD | Director/Board Member | 79 | 01-03-19 |
Director/Board Member | 65 | 21-02-20 | |
Gregory Freitag
BRD | Director/Board Member | 62 | 01-03-19 |
Frank Bedu-Addo
FOU | Founder | 59 | 15-03-19 |
Ilian Iliev
BRD | Director/Board Member | 48 | 08-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 679 275 | 35 209 588 ( 95,99 %) | 0 | 95,99 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,14% | 140 mln. | |
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |
- Beurs
- Aandelen
- Koers PDSB
- Onderneming PDS Biotechnology Corporation